Abstract
Several cancer vaccines are in various phases of clinical research. As vaccine therapy evolves, this method of treatment and/or preventing cancer will become more common. Part 2 of this column will describe some of the current vaccine studies and where vaccine therapy may be headed in the future.
Original language | English |
---|---|
Pages (from-to) | 598-599 |
Number of pages | 2 |
Journal | Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) |
Volume | 37 |
Issue number | 5 |
DOIs | |
State | Published - 1997 |
Bibliographical note
Funding Information:is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Pharmacy, and supported by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.
Funding
is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Pharmacy, and supported by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.
Funders | Funder number |
---|---|
Ameri can Pharmaceutical Asso ciation |
ASJC Scopus subject areas
- Pharmaceutical Science